Every open market buy and sale of X4 Pharmaceuticals, Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $12K bought and $463K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when XFOR insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an XFOR officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every XFOR insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Adam R CraigExecutive Chairman | Buy | 4,600 | $2.58 | $12K | 333,251 | Oct 19Form 4 |
| Oct 1, 2026 | David KirskeCFO | Sale | 11,767 | $2.86 | $34K | 155,983 | Oct 5Form 4 |
| Aug 12, 2026 | Adam R CraigExecutive Chairman | Sale | 47,436 | $4.44 | $211K | 328,651 | Aug 13Form 4 |
| Aug 12, 2026 | John VolponePresident | Sale | 24,576 | $4.44 | $109K | 265,305 | Aug 13Form 4 |
| Jun 30, 2026 | David KirskeCFO | Sale | 8,543 | $4.26 | $36K | 167,750 | Jul 1Form 4 |
| May 12, 2026 | David KirskeCFO | Sale | 16,961 | $4.29 | $73K | 176,293 | May 13Form 4 |
| Oct 23, 2025 | Adam R CraigExecutive Chairman | Buy | 86,206 | $2.90 | $250K | 376,087 | Oct 27Form 4 |
| May 16, 2025 | Mark BaldryChief Commercial Officer | Buy | 1,032 | $2.48 | $3K | 25,337 | May 20Form 4 |
| Jan 24, 2025 | Christophe Arbet-EngelsChief Medical Officer | Sale | 11,624 | $0.45 | $5K | 14,207 | Jan 27Form 4 |
| Jan 24, 2025 | Mary DiBiaseCOO | Sale | 22,258 | $0.45 | $10K | 490,980 | Jan 27Form 4 |
| Jan 24, 2025 | Mark BaldryChief Commercial Officer | Sale | 29,159 | $0.45 | $13K | 94,123 | Jan 27Form 4 |
| Jan 24, 2025 | Adam S. MostafaCFO | Sale | 74,773 | $0.45 | $34K | 0 | Jan 27Form 4 |
| Jan 24, 2025 | Paula RaganPresident and CEO | Sale | 76,473 | $0.45 | $34K | 1,087,386 | Jan 27Form 4 |
| Nov 15, 2024 | Mark BaldryChief Commercial Officer | Buy | 13,404 | $0.34 | $5K | 129,173 | Feb 14Form 4 |
| Nov 15, 2024 | Paula RaganPresident and CEO | Sale | 31,897 | $0.39 | $12K | 993,919 | Nov 19Form 4 |
XFOR insider trading FAQ
Are XFOR insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $12K of XFOR on the open market in 1 trades, and 3 sold $463K in 5 trades.
When did an XFOR insider last buy shares?
Adam R Craig (Executive Chairman) bought 4,600 shares for $12K on Oct 16, 2026, reported on Oct 19, 2026.
When did an XFOR insider last sell shares?
David Kirske (CFO) sold 11,767 shares for $34K on Oct 1, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
